Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 23, 2021
Reply to S. Fuji
Andreas Burchert, Stephan K Metzelder, Andreas Neubauer, et al.
Haematologica
|
January 7, 2017
Dasatinib and allogeneic stem cell transplantation enable sustained response in an elderly patient with <i>RCSD1-ABL1</i>-positive acute lymphoblastic leukemia
Miriam Frech, Lutz B Jehn, Kathleen Stabla, et al.
Leukemia & Lymphoma
|
February 11, 2015
Sorafenib induces paradoxical phosphorylation of the extracellular signal-regulated kinase pathway in acute myeloid leukemia cells lacking FLT3-ITD mutation
Fariba Fouladi, Lutz B Jehn, Stephan K Metzelder, et al.
Leukemia Research
|
October 7, 2017
Maintenance of cellular respiration indicates drug resistance in acute myeloid leukemia
Katharina Henkenius, Brandon H Greene, Christina Barckhausen, et al.
The Journal of Biological Chemistry
|
May 26, 2004
Identification of interaction partners and substrates of the cyclin A1-CDK2 complex
Sven Diederichs, Nicole Bäumer, Ping Ji, et al.
Leukemia & Lymphoma
|
January 16, 2019
Outcome of non-mold effective anti-fungal prophylaxis in patients at high-risk for invasive fungal infections after allogenic stem cell transplantation
Deborah Christen, Kristina Sohlbach, Stephan K Metzelder, et al.
British Journal of Haematology
|
September 24, 2024
Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study
Klaus Geissler, Zdenek Koristek, Teresa Bernal Del Castillo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 2020
Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With <i>FLT3</i>-Internal Tandem Duplication Mutation (SORMAIN)
Andreas Burchert, Gesine Bug, Lea V Fritz, et al.
Leukemia
|
January 12, 2026
Randomized phase 3 trial of Ropeginterferon alfa-2b versus surveillance after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia (ENDURE/CML-IX)
Andreas Burchert, Franck E Nicolini, Philipp le Coutre, et al.
Nature Medicine
|
April 11, 2018
Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells
Nimitha R Mathew, Francis Baumgartner, Lukas Braun, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 23, 2021
Reply to S. Fuji
Andreas Burchert, Stephan K Metzelder, Andreas Neubauer, et al.
Haematologica
|
January 7, 2017
Dasatinib and allogeneic stem cell transplantation enable sustained response in an elderly patient with <i>RCSD1-ABL1</i>-positive acute lymphoblastic leukemia
Miriam Frech, Lutz B Jehn, Kathleen Stabla, et al.
Leukemia & Lymphoma
|
February 11, 2015
Sorafenib induces paradoxical phosphorylation of the extracellular signal-regulated kinase pathway in acute myeloid leukemia cells lacking FLT3-ITD mutation
Fariba Fouladi, Lutz B Jehn, Stephan K Metzelder, et al.
Leukemia Research
|
October 7, 2017
Maintenance of cellular respiration indicates drug resistance in acute myeloid leukemia
Katharina Henkenius, Brandon H Greene, Christina Barckhausen, et al.
The Journal of Biological Chemistry
|
May 26, 2004
Identification of interaction partners and substrates of the cyclin A1-CDK2 complex
Sven Diederichs, Nicole Bäumer, Ping Ji, et al.
Leukemia & Lymphoma
|
January 16, 2019
Outcome of non-mold effective anti-fungal prophylaxis in patients at high-risk for invasive fungal infections after allogenic stem cell transplantation
Deborah Christen, Kristina Sohlbach, Stephan K Metzelder, et al.
British Journal of Haematology
|
September 24, 2024
Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study
Klaus Geissler, Zdenek Koristek, Teresa Bernal Del Castillo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 2020
Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With <i>FLT3</i>-Internal Tandem Duplication Mutation (SORMAIN)
Andreas Burchert, Gesine Bug, Lea V Fritz, et al.
Leukemia
|
January 12, 2026
Randomized phase 3 trial of Ropeginterferon alfa-2b versus surveillance after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia (ENDURE/CML-IX)
Andreas Burchert, Franck E Nicolini, Philipp le Coutre, et al.
Nature Medicine
|
April 11, 2018
Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells
Nimitha R Mathew, Francis Baumgartner, Lukas Braun, et al.
Page
of 2